Name | Title | Contact Details |
---|
Trellis Bioscience is a leader in identifying rare protective antibodies by screening human blood cells.
Biomea Fusion, Inc. was formed in 2017 by a small group of biotech executives. We are dedicated to developing innovative medicines for patients. It is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care.
Making advanced diagnostics and adoptive cell therapies more accessible by working from the bottom up via synthetic cells.
Chelsea Therapeutics is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Endocyte Inc is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.